CMC Asset Lead - Immunotherapy, IND Enablement

Shennon Biotechnologies; United States; Remote; USD 250,000 - 380,000; Full time

Job summary

Shennon Biotechnologies, based in San Francisco, seeks a senior CMC leader to own end-to-end CMC for a trispecific TCE program from discovery to IND. You will coordinate cross-functional teams, data packages, and regulatory strategy to move programs forward.

In this role, you will lead CDMO selection, monitor quality and budgets, and drive regulatory submissions. The ideal candidate has 12+ years in biologics CMC, with demonstrated IND experience and strong leadership in fast-paced biotech

Qualifications

• PhD or BS/MS with 12+ years in biologics CMC.
• Experience taking a biologic to IND and managing CDMOs.

Responsibilities

• Own CMC end-to-end for a trispecific TCE program from discovery to IND.
• Lead competitive CDMO selection, quality, budget, and regulatory submissions.

Skills

CMC leadership

IND submissions

CDMO management

Biologics experience

Education

PhD or BS/MS in biologics/CMC

Job description

Shennon Biotechnologies, based in San Francisco, seeks a senior CMC leader to own end-to-end CMC for a trispecific TCE program from discovery to IND. You will coordinate cross-functional teams, data packages, and regulatory strategy to move programs forward.

In this role, you will lead CDMO selection, monitor quality and budgets, and drive regulatory submissions. The ideal candidate has 12+ years in biologics CMC, with demonstrated IND experience and strong leadership in fast-paced biotech